BPE:MILBPER Banca S.p.A. Analysis
Data as of 2026-05-23 - not real-time
€11.49
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
BPER Banca delivers solid profitability with operating margins well above typical banking standards and a dividend yield that sits in the high double‑digit range, making the stock attractive to income‑focused investors. The valuation metrics show a price‑to‑earnings multiple comfortably below the sector average and a price‑to‑book ratio that suggests the market is pricing the bank at a discount to its book value. Technical signals point to a bullish price trend supported by a clear support level just above the current price, while the MACD has turned bearish and the RSI hovers in a neutral zone, indicating short‑term caution. The stock’s beta is low, reflecting limited sensitivity to broader market swings, and the 30‑day volatility, though elevated for a bank, remains manageable. Analyst consensus is positive with a “buy” rating and target prices well above today’s level, implying a sizable upside potential.
Given the combination of strong cash generation, a sustainable payout ratio, and an undervalued pricing relative to peers, the stock appears positioned for a multi‑period upside. Investors should monitor the nearest support level for any breach and keep an eye on the MACD trend reversal, but the overall fundamentals and dividend profile support a buy stance for medium‑term horizons while maintaining a watchful short‑term stance.
Given the combination of strong cash generation, a sustainable payout ratio, and an undervalued pricing relative to peers, the stock appears positioned for a multi‑period upside. Investors should monitor the nearest support level for any breach and keep an eye on the MACD trend reversal, but the overall fundamentals and dividend profile support a buy stance for medium‑term horizons while maintaining a watchful short‑term stance.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- price near immediate support
- bearish MACD histogram
- neutral RSI indicating limited upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- undervalued PE relative to industry
- high dividend yield with sustainable payout
- target price upside above current level
Long Term
> 3 yearsNeutral
Model confidence: 7/10
Key Factors
- stable earnings and strong operating margins
- low beta reducing market‑wide risk exposure
- consistent dividend policy supporting total return
Key Metrics & Analysis
Financial Health
Revenue Growth24.10%
Profit Margin30.23%
P/E Ratio11.1
ROE13.13%
ROA1.13%
P/B Ratio1.3
Industry P/E16.8
Technical Analysis
TrendBullish
RSI40.1
Support€11.36
Resistance€13.22
MA 20€12.24
MA 50€11.81
MA 200€10.83
MACDBearish
VolumeStable
Fear & Greed Index91.61
Valuation
Target Price€13.96
Upside/Downside21.49%
GradeUndervalued
TypeBlend
Dividend Yield10.96%
Risk Assessment
Beta0.41
Volatility32.07%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.